Table 3.
Factors Associated with Overweight and Obesity in Univariable Analyses (Multinomial Logistic Regression, ANRS CO22 Hepather Cohort, n=3706)
| Variables | Overweight (25 ≤ BMI <30), RRR [95% CI] | p | Obesity (BMI ≥30), RRR [95% CI] | p |
|---|---|---|---|---|
| Cannabis use | ||||
| Never (Ref.) | 1 | 0.006 | 1 | 0.005 |
| Former | 0.99 [0.67–1.44] | 0.941 | 1.07 [0.65–1.77] | 0.786 |
| Current | 0.46 [0.29–0.74] | 0.001 | 0.09 [0.02–0.39] | 0.001 |
| Gender | ||||
| Male (Ref.) | 1 | 1 | ||
| Female | 0.71 [0.61–0.83] | <10−3 | 1.60 [1.32–1.94] | <10−3 |
| Age at baseline, years | 1.02 [1.01–1.02] | <10−3 | 1.03 [1.02–1.03] | <10−3 |
| Coffee consumption | ||||
| 0 cup/day (Ref.) | 1 | 0.057 | 1 | 0.509 |
| 1–2 cups/day | 1.05 [0.89–1.24] | 0.552 | 1.04 [0.83–1.31] | 0.713 |
| ≥3 cups/day | 1.24 [1.03–1.48] | 0.020 | 1.15 [0.90–1.48] | 0.250 |
| Tobacco smoking | ||||
| Never (Ref.) | 1 | <10−3 | 1 | <10−3 |
| Former | 1.46 [1.20–1.77] | <10−3 | 1.42 [1.10–1.83] | 0.006 |
| Current | 0.93 [0.77–1.13] | 0.477 | 0.64 [0.48–0.85] | 0.002 |
| Alcohol consumption | ||||
| Abstinent without past unhealthy use (Ref.) | 1 | 0.182 | 1 | 0.002 |
| Abstinent with past unhealthy use | 1.48 [1.00–2.18] | 0.048 | 2.29 [1.46–3.60] | <10−3 |
| Moderate use | 1.09 [0.94–1.26] | 0.261 | 1.08 [0.88–1.33] | 0.446 |
| Unhealthy use | 1.23 [0.68–2.23] | 0.498 | 1.68 [0.82–3.46] | 0.158 |
| Living in poverty | ||||
| No (Ref.) | 1 | 1 | ||
| Yes | 1.16 [1.00–1.34] | 0.047 | 1.66 [1.37–2.02] | <10−3 |
| Education level | ||||
| < Secondary school diploma (Ref.) | 1 | 1 | ||
| > Secondary school diploma | 0.84 [0.73–0.97] | 0.018 | 0.53 [0.43–0.64] | <10−3 |
| Employed | ||||
| No (Ref.) | 1 | 1 | ||
| Yes | 0.97 [0.83–1.12] | 0.631 | 0.64 [0.53–0.78] | <10−3 |
| Advanced liver fibrosisa | ||||
| No (Ref.) | 1 | 1 | ||
| Yes | 0.86 [0.59–1.24] | 0.416 | 1.19 [0.76–1.87] | 0.438 |
| Time since HBV diagnosis, years | 1.01 [1.00–1.01] | 0.189 | 1.00 [0.99–1.01] | 0.727 |
| HBV treatment status | ||||
| Never treated (Ref.) | 1 | 0.264 | 1 | 0.254 |
| History of treatment | 0.88 [0.65–1.20] | 0.429 | 0.68 [0.43–1.08] | 0.101 |
| Ongoing treatment | 0.89 [0.77–1.03] | 0.117 | 0.95 [0.78–1.15] | 0.586 |
Bold values highlight the global p-value for variables with more than 2 modalities.
Advanced liver fibrosis was defined as a FIB-4 score >3.25.31
RRR, relative risk ratio.